European Medicines Agency Committee Starts Safety Review of Cold Medicines
A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Copyright 2026 Reuters. Click for restrictions.
Popular Today
- Flood Insurance Gap Will Squeeze Local Governments and Homeowners, Moody’s Says
- 5 Years After Surfside Collapse: Safer Condos, More Transparency for Underwriters
- Virginia’s New Gun Laws Challenged by Some Local Prosecutors and Lawsuits
- KPMG Australia Scandal Widens After it Confirms Optus Data Was Misused